Nebreda / Selander / Austin / Milano / Redwood City / Milan / Merrell / Naples / San Jose / Monza / Hilden / Rockville / Boston / Cambridge / Phong / Foster City / Darmstadt / San Diego / Henry / /
Company
Kellogg / Systat Software Inc. / Novartis Pharma / Millipore / Qiagen / Ingenuity Systems Inc. / Novartis Pharmaceuticals / Cambrex / Merck / Data / GE Healthcare / BD Biosciences / Life Technologies Europe BV / DU145R80 / IgG / LG / ZOL / Bio-Plex / Luminex / Invitrogen Corporation / Becton Dickinson / Santa Cruz Biotechnology Inc. / Corning Incorporated / Bio-Rad Lab Inc. / EMT / Macmillan Publishers Limited / /
Country
Switzerland / United Kingdom / Denmark / Germany / Italy / Belgium / United States / /
Currency
pence / / /
Event
FDA Phase / /
Facility
University of Verona / National Cancer Institute of Naples / Second University of Naples / /
IndustryTerm
cancer therapies / Online Publication / clinical management / /
MedicalCondition
osteoclast-mediated bone resorption / JE / metastatic disease / androgen-refractory metastatic prostate cancer / prostatic disease / bone resorption / prostate cancer / breast cancer / refractory metastatic prostate cancer / adenocarcinoma / tumor / cancer / prostatic intraepithelial neoplasia / carcinogenesis / osteosarcoma / bone metastases / bone metastasis / diseases / Cancer Prostate cancer / tumours / several neoplasms / metastasis / carcinoma / MS / dissociation / cancers / common cancer / Disease / shock / tumour / pain / metastatic cancer / inflammation / /
2Experimental Pharmacology Unit / Experimental Pharmacology Unit / University of Verona / Verona / Department of Research / African Union / Italian Ministry of Education / Ministry of Health / National Cancer Institute of Naples / Second University of Naples / Naples / /
Person
Alessandra Trocino / Milone / Emerging / / /
Position
model for the mechanisms underlying the acquired resistance / mediator / Major / representative / Miner / Manager / Italy *Corresponding author / /
Presentazione standard di PowerPoint